EXUMA Biotechnology

  • Our Science Expand
      back
    • Logic-gated CAR-T
    • Cell Therapy Delivery Systems
    • Big Data Analytics
  • Our Company Expand
      back
    • Strategic Relationships
    • Our Team
  • News & Resources Expand
      back
    • Posters
    • Presentations
  • Work at EXUMA Expand
      back
    • Job Openings
  • Contact
Skip to content
September 24 2020October 1, 2020 by Alissa Kerner

Speeding the Delivery of CAR-T Therapies While Cutting the Cost

Chairman & CEO Greg Frost speaks with Danny Levine from The BIO Report on making CAR-T therapies more accessible and affordable for patients

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

 

The Bio Report · Speeding the Delivery of CAR-T Therapies While Cutting the Cost
  • Jobs
  • Legal
    • LinkedIn
    • Twitter
  • ©2020 EXUMA Biotechnology